Milestone Pharmaceuticals Inc. reports

Company location: Montreal, Quebec, Canada
Fiscal year end: 31 December

Milestone Pharmaceuticals Inc. has filed 406 SEC EDGAR filings since 30 Jul 2007

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 201-225 of 405 matching filings.

Per page

25

Current page

9

4

FORM 4 SUBMISSION

Filing date: 15 Sep 2022
Reporting date: 14 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 09 Sep 2022
Reporting date: 07 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 17 Aug 2022
Reporting date: 09 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Aug 2022
Reporting date: 05 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Aug 2022
Reporting date: 05 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Aug 2022
Reporting date: 05 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Aug 2022
Reporting date: 05 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 11 Aug 2022
Reporting date: 05 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38899

FORM 8-K

Filing date: 10 Aug 2022
Reporting date: 10 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38899

10-Q

Filing date: 10 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38899

FORM 8-K

Filing date: 08 Jul 2022
Reporting date: 08 Jul 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 01 Jun 2022
Reporting date: 31 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38899

10-Q

Filing date: 12 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-38899

DEFA14A

Filing date: 02 May 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-38899

DEF 14A

Filing date: 02 May 2022
Reporting date: 05 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

PRE 14A File 001-38899

PRE 14A

Filing date: 22 Apr 2022
Reporting date: 23 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38899

FORM 8-K

Filing date: 24 Mar 2022
Reporting date: 24 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-8 File 333-263807

FORM S-8

Filing date: 24 Mar 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-38899

10-K

Filing date: 24 Mar 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Mar 2022
Reporting date: 21 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Mar 2022
Reporting date: 21 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 23 Mar 2022
Reporting date: 21 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 17 Feb 2022
Reporting date: 15 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 17 Feb 2022
Reporting date: 15 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38899

FORM 8-K

Filing date: 16 Feb 2022
Reporting date: 15 Feb 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .